董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Barbara R. Paul | 女 | Director | 63 | 16.10万美元 | 未持股 | 2017-04-28 |
| Robert A. Gunst | 男 | Chairman | 67 | 28.45万美元 | 未持股 | 2017-04-28 |
| James B. Hawkins | 男 | Chief Executive Officer,Director, President | 60 | 523.48万美元 | 未持股 | 2017-04-28 |
| Doris E. Engibous | 女 | Director | 62 | 22.20万美元 | 未持股 | 2017-04-28 |
| William M. Moore | 男 | Director | 66 | 23.45万美元 | 未持股 | 2017-04-28 |
| Kenneth E. Ludlum | 男 | Director | 62 | 23.95万美元 | 未持股 | 2017-04-28 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| James B. Hawkins | 男 | Chief Executive Officer,Director, President | 60 | 523.48万美元 | 未持股 | 2017-04-28 |
| D. Christopher Chung | 男 | Vice President Medical Affairs, Quality & Regulatory | 62 | 73.85万美元 | 未持股 | 2017-04-28 |
| Kenneth M. Traverso | 男 | Vice President and General Manager, Newborn Care SBU | 65 | 86.51万美元 | 未持股 | 2017-04-28 |
| Jonathan Kennedy | 男 | Executive Vice President and Chief Financial Officer | 54 | 162.82万美元 | 未持股 | 2017-04-28 |
| Austin F. Noll, III | 男 | Vice President and General Manager, Neurology SBU | 58 | 95.81万美元 | 未持股 | 2017-04-28 |
董事简历
中英对照 | 中文 | 英文- Barbara R. Paul
-
BarbaraR.Paul担任梦百合公司的顾问和董事会成员。除了她在我们董事会的角色，她在董事会任职，并担任Natus Medical，Inc.的董事会主席。Nasdaq:NTUS是一家领先的梦百合产品和服务提供商，用于神经功能障碍、癫痫、睡眠障碍、新生儿护理、听力障碍以及平衡和行动障碍的筛查、检测、治疗、监测和跟踪。她曾担任CHS公司的高级副总裁兼首席医疗官（从2007年7月到2014年），领导多家医院的收购和整合，并负责加强公司与附属医生的关系、培养医生领导者和提供战略指导。在加入CHS之前，Paul博士是Beverly Enterprises，Inc.（现Golden Living，Inc.）的高级副总裁兼首席医疗官。从1999年到2004年，她曾任职the Federal Medicare Program（the Centers for Medicare&Medicaid Services，CMS），负责克林顿总统和布什总统的任命，在那里她曾担任质量测量和健康评估部门的董事。Paul博士在威斯康星大学麦迪逊分校（University of Wisconsin-Madison）获得理学学士学位，并在斯坦福大学医学院（Stanford University School of Medicine）获得医学学位。Paul博士的职业生涯建立在十二年作为董事会认证的内科医生和全职初级保健医生的基础上。
Barbara R. Paul serves as an advisor and board member to healthcare companies. In addition to her role on our Board, she serves on the board and as the board chair of Natus Medical, Inc. NASDAQ: NTUS, a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of neurological dysfunction, epilepsy, sleep disorders, newborn care, hearing impairment and balance and mobility disorders. She served as Senior Vice President & Chief Medical Officer at CHS from July 2007 through 2014 providing leadership for a number of hospital acquisitions and integrations and being responsible for enhancing the company's relationship with affiliated physicians, developing physician leaders, and providing strategic direction. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.). From 1999 to 2004 she worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush, where she was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin-Madison and earned her medical degree from Stanford University School of Medicine. Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician. - BarbaraR.Paul担任梦百合公司的顾问和董事会成员。除了她在我们董事会的角色，她在董事会任职，并担任Natus Medical，Inc.的董事会主席。Nasdaq:NTUS是一家领先的梦百合产品和服务提供商，用于神经功能障碍、癫痫、睡眠障碍、新生儿护理、听力障碍以及平衡和行动障碍的筛查、检测、治疗、监测和跟踪。她曾担任CHS公司的高级副总裁兼首席医疗官（从2007年7月到2014年），领导多家医院的收购和整合，并负责加强公司与附属医生的关系、培养医生领导者和提供战略指导。在加入CHS之前，Paul博士是Beverly Enterprises，Inc.（现Golden Living，Inc.）的高级副总裁兼首席医疗官。从1999年到2004年，她曾任职the Federal Medicare Program（the Centers for Medicare&Medicaid Services，CMS），负责克林顿总统和布什总统的任命，在那里她曾担任质量测量和健康评估部门的董事。Paul博士在威斯康星大学麦迪逊分校（University of Wisconsin-Madison）获得理学学士学位，并在斯坦福大学医学院（Stanford University School of Medicine）获得医学学位。Paul博士的职业生涯建立在十二年作为董事会认证的内科医生和全职初级保健医生的基础上。
- Barbara R. Paul serves as an advisor and board member to healthcare companies. In addition to her role on our Board, she serves on the board and as the board chair of Natus Medical, Inc. NASDAQ: NTUS, a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of neurological dysfunction, epilepsy, sleep disorders, newborn care, hearing impairment and balance and mobility disorders. She served as Senior Vice President & Chief Medical Officer at CHS from July 2007 through 2014 providing leadership for a number of hospital acquisitions and integrations and being responsible for enhancing the company's relationship with affiliated physicians, developing physician leaders, and providing strategic direction. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.). From 1999 to 2004 she worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush, where she was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin-Madison and earned her medical degree from Stanford University School of Medicine. Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician.
- Robert A. Gunst
-
Robert A. Gunst于2004年6月加入董事会，于2004年9月获委任为董事会主席。现为私人投资者。1990到1999年担任The Good Guys公司（一家电子产品零售商）的总裁兼首席执行官，1986年至1999年担任董事。此前，在嘉康利公司、La Petite Boulangerie公司和百事食品国际（百事公司的两家附属公司）、维多利亚车站股份有限公司和芝加哥第一国民银行担任高级管理人员及董事职位。他持有达特茅斯学院的经济学学士学位，在芝加哥大学研究生院获得工商管理硕士学位。
Robert A. Gunst joined the Board in June 2004 and was appointed Chairman of the Board in September 2004. Mr. Gunst has been a private investor since 1999. Mr. Gunst served as president and chief executive officer of The Good Guys, Inc., an electronics retailer, from 1990 to 1999 and as a member of its board of directors from 1986 to 1999. Prior to joining The Good Guys, Mr. Gunst held senior management and director positions at Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods International, both subsidiaries of PepsiCo, Inc., Victoria Station Incorporated, and The First National Bank of Chicago. He holds a Bachelor of Arts degree in Economics from Dartmouth College and a Masters Degree in Business Administration from the University of Chicago’s Graduate School of Business. - Robert A. Gunst于2004年6月加入董事会，于2004年9月获委任为董事会主席。现为私人投资者。1990到1999年担任The Good Guys公司（一家电子产品零售商）的总裁兼首席执行官，1986年至1999年担任董事。此前，在嘉康利公司、La Petite Boulangerie公司和百事食品国际（百事公司的两家附属公司）、维多利亚车站股份有限公司和芝加哥第一国民银行担任高级管理人员及董事职位。他持有达特茅斯学院的经济学学士学位，在芝加哥大学研究生院获得工商管理硕士学位。
- Robert A. Gunst joined the Board in June 2004 and was appointed Chairman of the Board in September 2004. Mr. Gunst has been a private investor since 1999. Mr. Gunst served as president and chief executive officer of The Good Guys, Inc., an electronics retailer, from 1990 to 1999 and as a member of its board of directors from 1986 to 1999. Prior to joining The Good Guys, Mr. Gunst held senior management and director positions at Shaklee Corporation, La Petite Boulangerie, Inc. and PepsiCo Foods International, both subsidiaries of PepsiCo, Inc., Victoria Station Incorporated, and The First National Bank of Chicago. He holds a Bachelor of Arts degree in Economics from Dartmouth College and a Masters Degree in Business Administration from the University of Chicago’s Graduate School of Business.
- James B. Hawkins
-
James B. Hawkins，2007年10月以来，他担任公司的董事。2004年4月以来，他担任Natus Medical Incorporated的总裁、首席执行官和董事。加入Natus Medical之前的1985年到2004年1月，他曾是Invivo Corporation（多参数生理信号监测设备的开发商和制造商）和其前身公司的总裁、首席执行官和董事。从1986年到2004年1月，他担任 Invivo的秘书。他获得圣塔克拉拉大学（Santa Clara University）的商业学士学位和旧金山州立大学（San Francisco State University）的工商管理硕士学位。
James B. Hawkins was the President, Chief Executive Officer and member of the Board of Directors of Nat Medical Incorporated, a leading manufacturer of medical devices and software and a service provider for the newborn care, neurology, sleep, hearing and balance markets. Prior to joining Nat, Mr. Hawkins was President, Chief Executive Officer, and a director of Invivo Corporation, a provider of MRI safe patient monitoring, and Chief Executive Officer and Chief Financial Officer of Sensor Control Corporation. Mr. Hawkins currently serves as a director of Iradimed Corporation and AudioEye, Inc.Mr. Hawkins has extensive risk management experience gained through the vario executive and board positions that he has held.He earned his undergraduate degree in Biness Commerce from Santa Clara University and holds a Masters of Biness Administration degree in Finance from San Francisco State University. - James B. Hawkins，2007年10月以来，他担任公司的董事。2004年4月以来，他担任Natus Medical Incorporated的总裁、首席执行官和董事。加入Natus Medical之前的1985年到2004年1月，他曾是Invivo Corporation（多参数生理信号监测设备的开发商和制造商）和其前身公司的总裁、首席执行官和董事。从1986年到2004年1月，他担任 Invivo的秘书。他获得圣塔克拉拉大学（Santa Clara University）的商业学士学位和旧金山州立大学（San Francisco State University）的工商管理硕士学位。
- James B. Hawkins was the President, Chief Executive Officer and member of the Board of Directors of Nat Medical Incorporated, a leading manufacturer of medical devices and software and a service provider for the newborn care, neurology, sleep, hearing and balance markets. Prior to joining Nat, Mr. Hawkins was President, Chief Executive Officer, and a director of Invivo Corporation, a provider of MRI safe patient monitoring, and Chief Executive Officer and Chief Financial Officer of Sensor Control Corporation. Mr. Hawkins currently serves as a director of Iradimed Corporation and AudioEye, Inc.Mr. Hawkins has extensive risk management experience gained through the vario executive and board positions that he has held.He earned his undergraduate degree in Biness Commerce from Santa Clara University and holds a Masters of Biness Administration degree in Finance from San Francisco State University.
- Doris E. Engibous
-
Doris E. Engibous，女，目前担任医疗技术公司的顾问和高管。从2004年到2010年担任Hemosphere公司，（早期商业化阶段，投资创业投资资金，医疗技术公司）的总裁兼首席执行官。在2004年之前，从2000年到2003年担任Nellcor泰科医疗集团/泰科国际有限公司（现在Covidien公司的业务）的总裁。2006至2010年担任全国肾脏基金会明尼苏达州，达科塔州和爱荷华州的董事会成员。她持有密歇根大学化学工程学位。
Doris E. Engibous has served as a consultant and advisor to medical technology companies and executives since 2010. From 2004 to 2010 she served as President and CEO of Hemosphere, Inc., an early commercialization stage, venture capital funded, medical technology company, prior to its acquisition by CryoLife, Inc. NYSE: CRY. Prior to 2004 Ms. Engibous served from 2000 through 2003 as President of Nellcor, a business of Tyco Healthcare Group/Tyco International, Ltd. (now Covidien/Medtronic, NYSE: MDT). Since 2015 Ms. Engibous has served on the board of directors of GI Supply, Inc., a family-owned medical technology company. Ms. Engibous served on the board of directors of the National Kidney Foundation serving Minnesota, the Dakotas and Iowa from 2006 to 2010. She holds a Bachelor of Science degree in Chemical Engineering from the University of Michigan. - Doris E. Engibous，女，目前担任医疗技术公司的顾问和高管。从2004年到2010年担任Hemosphere公司，（早期商业化阶段，投资创业投资资金，医疗技术公司）的总裁兼首席执行官。在2004年之前，从2000年到2003年担任Nellcor泰科医疗集团/泰科国际有限公司（现在Covidien公司的业务）的总裁。2006至2010年担任全国肾脏基金会明尼苏达州，达科塔州和爱荷华州的董事会成员。她持有密歇根大学化学工程学位。
- Doris E. Engibous has served as a consultant and advisor to medical technology companies and executives since 2010. From 2004 to 2010 she served as President and CEO of Hemosphere, Inc., an early commercialization stage, venture capital funded, medical technology company, prior to its acquisition by CryoLife, Inc. NYSE: CRY. Prior to 2004 Ms. Engibous served from 2000 through 2003 as President of Nellcor, a business of Tyco Healthcare Group/Tyco International, Ltd. (now Covidien/Medtronic, NYSE: MDT). Since 2015 Ms. Engibous has served on the board of directors of GI Supply, Inc., a family-owned medical technology company. Ms. Engibous served on the board of directors of the National Kidney Foundation serving Minnesota, the Dakotas and Iowa from 2006 to 2010. She holds a Bachelor of Science degree in Chemical Engineering from the University of Michigan.
- William M. Moore
-
William M. Moore，担任公司董事会主席，并担任公司总裁兼首席执行官。自2007年9月起担任公司董事，自2010年9月起担任公司董事会主席，自2012年8月起担任公司总裁兼首席执行官。Moore先生于2007年9月至2010年7月担任公司薪酬委员会成员，并于2009年2月至2012年10月担任公司提名和治理委员会主席。摩尔先生目前还担任Natus Medical Incorporated的董事会成员，Natus Medical Incorporated是他于1990年与他人共同创立的一家上市公司，并担任Natus Medical Incorporated的首席执行官至1993年。Natus Medical Incorporated是一家医疗保健产品提供商，用于听力障碍、神经功能障碍、癫痫、睡眠障碍以及某些新生儿状况等常见医疗疾病的筛查、检测、治疗、监测和跟踪。Moore在2004年2月至2008年6月期间担任私募股权公司BlueLine Partners的顾问。从2008年2月到2010年6月，Moore先生在Urologix, Inc.的董事会任职，Urologix, Inc.是一家上市公司，开发、制造和销售用于治疗泌尿系统疾病的微创医疗产品。
William M. Moore,serves as the Chairman of the Company's Board of Directors and as the President and Chief Executive Officer of the Company. He has served as a director of the Company since September 2007 as Chairman of the Company's Board of Directors since September 2010 and as the President and Chief Executive Officer of the Company since August 2012. Mr. Moore served as a member of the Company's Compensation Committee from September 2007 to July 2010 and as the Chairman of the Company's Nominating and Governance Committee from February 2009 to October 2012.Mr. Moore also currently serves on the board of directors of Natus Medical Incorporated, a public company he co-founded in 1990 and for which he served as CEO until 1993. Natus Medical Incorporated is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Mr. Moore served as a consultant to BlueLine Partners, a private equity firm, from February 2004 until June 2008. From February 2008 to June 2010 Mr. Moore served on the board of directors of Urologix, Inc., a public company that develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. - William M. Moore，担任公司董事会主席，并担任公司总裁兼首席执行官。自2007年9月起担任公司董事，自2010年9月起担任公司董事会主席，自2012年8月起担任公司总裁兼首席执行官。Moore先生于2007年9月至2010年7月担任公司薪酬委员会成员，并于2009年2月至2012年10月担任公司提名和治理委员会主席。摩尔先生目前还担任Natus Medical Incorporated的董事会成员，Natus Medical Incorporated是他于1990年与他人共同创立的一家上市公司，并担任Natus Medical Incorporated的首席执行官至1993年。Natus Medical Incorporated是一家医疗保健产品提供商，用于听力障碍、神经功能障碍、癫痫、睡眠障碍以及某些新生儿状况等常见医疗疾病的筛查、检测、治疗、监测和跟踪。Moore在2004年2月至2008年6月期间担任私募股权公司BlueLine Partners的顾问。从2008年2月到2010年6月，Moore先生在Urologix, Inc.的董事会任职，Urologix, Inc.是一家上市公司，开发、制造和销售用于治疗泌尿系统疾病的微创医疗产品。
- William M. Moore,serves as the Chairman of the Company's Board of Directors and as the President and Chief Executive Officer of the Company. He has served as a director of the Company since September 2007 as Chairman of the Company's Board of Directors since September 2010 and as the President and Chief Executive Officer of the Company since August 2012. Mr. Moore served as a member of the Company's Compensation Committee from September 2007 to July 2010 and as the Chairman of the Company's Nominating and Governance Committee from February 2009 to October 2012.Mr. Moore also currently serves on the board of directors of Natus Medical Incorporated, a public company he co-founded in 1990 and for which he served as CEO until 1993. Natus Medical Incorporated is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Mr. Moore served as a consultant to BlueLine Partners, a private equity firm, from February 2004 until June 2008. From February 2008 to June 2010 Mr. Moore served on the board of directors of Urologix, Inc., a public company that develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders.
- Kenneth E. Ludlum
-
Kenneth E. Ludlum自2014年3月起担任CareDx公司的财务总监。从2011年4月至2013年10月担任Endogastric解决方案公司的副总裁兼财务总监，兼执行处首长。从2009年12月至2011年3月担任董事会成员，担任了顾问，并投资于一些私人医疗和生物技术公司。 2008年4月至2009年11月，他担任Paracor医疗公司的高级副总裁，负责财务及行政，财务总监。在此之前，还担任另外两个公开上市的公司——1995年至2000年Perclose公司和1992年至1994年Alteon公司的首席财务官。他还担任几个公共和私人医疗或生物技术公司审核委员会主席和董事。持有利哈伊大学的工商管理理学士学位和哥伦比亚大学研究生院的工商管理硕士学位。
Kenneth E. Ludlum has served as a member of Dermavant Sciences Ltd board of directors since May 2019. Since April 2019 Mr. Ludum has served as a member of the board of directors of IRIDEX Corporation, a medical technology company. Since July 2015 Mr. Ludlum has served as a member of the board of directors and chairperson of the audit committee of Personalis, Inc. a biotechnology company. Since 2002 Mr. Ludlum has served as a member of the board of directors and chairman of the audit committee at NATUS Medical Inc. From March 2014 to June 2016 Mr. Ludlum served as chief financial officer of CareDx Inc., a biotechnology company. From February 2014 to March 2015 Mr. Ludlum served as chief financial officer and head of operations at EndoGastric Solutions, Inc., a medical technology company. Mr. Ludlum earned a B.S. from Lehigh University and an M.B.A. from Columbia Business School. - Kenneth E. Ludlum自2014年3月起担任CareDx公司的财务总监。从2011年4月至2013年10月担任Endogastric解决方案公司的副总裁兼财务总监，兼执行处首长。从2009年12月至2011年3月担任董事会成员，担任了顾问，并投资于一些私人医疗和生物技术公司。 2008年4月至2009年11月，他担任Paracor医疗公司的高级副总裁，负责财务及行政，财务总监。在此之前，还担任另外两个公开上市的公司——1995年至2000年Perclose公司和1992年至1994年Alteon公司的首席财务官。他还担任几个公共和私人医疗或生物技术公司审核委员会主席和董事。持有利哈伊大学的工商管理理学士学位和哥伦比亚大学研究生院的工商管理硕士学位。
- Kenneth E. Ludlum has served as a member of Dermavant Sciences Ltd board of directors since May 2019. Since April 2019 Mr. Ludum has served as a member of the board of directors of IRIDEX Corporation, a medical technology company. Since July 2015 Mr. Ludlum has served as a member of the board of directors and chairperson of the audit committee of Personalis, Inc. a biotechnology company. Since 2002 Mr. Ludlum has served as a member of the board of directors and chairman of the audit committee at NATUS Medical Inc. From March 2014 to June 2016 Mr. Ludlum served as chief financial officer of CareDx Inc., a biotechnology company. From February 2014 to March 2015 Mr. Ludlum served as chief financial officer and head of operations at EndoGastric Solutions, Inc., a medical technology company. Mr. Ludlum earned a B.S. from Lehigh University and an M.B.A. from Columbia Business School.
高管简历
中英对照 | 中文 | 英文- James B. Hawkins
James B. Hawkins，2007年10月以来，他担任公司的董事。2004年4月以来，他担任Natus Medical Incorporated的总裁、首席执行官和董事。加入Natus Medical之前的1985年到2004年1月，他曾是Invivo Corporation（多参数生理信号监测设备的开发商和制造商）和其前身公司的总裁、首席执行官和董事。从1986年到2004年1月，他担任 Invivo的秘书。他获得圣塔克拉拉大学（Santa Clara University）的商业学士学位和旧金山州立大学（San Francisco State University）的工商管理硕士学位。
James B. Hawkins was the President, Chief Executive Officer and member of the Board of Directors of Nat Medical Incorporated, a leading manufacturer of medical devices and software and a service provider for the newborn care, neurology, sleep, hearing and balance markets. Prior to joining Nat, Mr. Hawkins was President, Chief Executive Officer, and a director of Invivo Corporation, a provider of MRI safe patient monitoring, and Chief Executive Officer and Chief Financial Officer of Sensor Control Corporation. Mr. Hawkins currently serves as a director of Iradimed Corporation and AudioEye, Inc.Mr. Hawkins has extensive risk management experience gained through the vario executive and board positions that he has held.He earned his undergraduate degree in Biness Commerce from Santa Clara University and holds a Masters of Biness Administration degree in Finance from San Francisco State University.- James B. Hawkins，2007年10月以来，他担任公司的董事。2004年4月以来，他担任Natus Medical Incorporated的总裁、首席执行官和董事。加入Natus Medical之前的1985年到2004年1月，他曾是Invivo Corporation（多参数生理信号监测设备的开发商和制造商）和其前身公司的总裁、首席执行官和董事。从1986年到2004年1月，他担任 Invivo的秘书。他获得圣塔克拉拉大学（Santa Clara University）的商业学士学位和旧金山州立大学（San Francisco State University）的工商管理硕士学位。
- James B. Hawkins was the President, Chief Executive Officer and member of the Board of Directors of Nat Medical Incorporated, a leading manufacturer of medical devices and software and a service provider for the newborn care, neurology, sleep, hearing and balance markets. Prior to joining Nat, Mr. Hawkins was President, Chief Executive Officer, and a director of Invivo Corporation, a provider of MRI safe patient monitoring, and Chief Executive Officer and Chief Financial Officer of Sensor Control Corporation. Mr. Hawkins currently serves as a director of Iradimed Corporation and AudioEye, Inc.Mr. Hawkins has extensive risk management experience gained through the vario executive and board positions that he has held.He earned his undergraduate degree in Biness Commerce from Santa Clara University and holds a Masters of Biness Administration degree in Finance from San Francisco State University.
- D. Christopher Chung
D. Christopher Chung，医学博士，自2011年6月起担任公司副总裁，负责医疗事务、质量和法规。从2003年6月至2011年6月担任集团副总裁，负责研发和工程。从2000年10月至2003年2月担任医疗主任。从2000年到2010年担任在旧金山的加州太平洋医疗中心的儿科医生。从1997年6月至2000年6月在波士顿儿童医院和哈佛医学院受训成为一名儿科医生。从1986年5月至1993年7月担任Nellcor（一家医疗设备公司）的工程师。从宾夕法尼亚大学获得文学士学位，主修计算机数学；医学博士学位来自宾夕法尼亚州的哈内曼大学医学院。他是委员会认证的儿科医生，是美国儿科科学院院士。
D. Christopher Chung has served as our Vice President Medical Affairs, Quality and Regulatory since June 2003 and has served as our Vice President Medical Affairs since February 2003. Dr. Chung also served as our Medical Director from October 2000 to February 2003. From August 2000 to present, Dr. Chung has also served as a Pediatric Hospitalist at the California Pacific Medical Center in San Francisco. From June 1997 to June 2000 Dr. Chung trained as a pediatric resident at Boston Children's Hospital and Harvard Medical School. From May 1986 to July 1993 Dr. Chung worked as an Engineer at Nellcor, a medical device company. Dr. Chung holds a Bachelor of Arts degree in Computer Mathematics from the University of Pennsylvania and a Doctor of Medicine degree from the Medical College of Pennsylvania-Hahnemann University School of Medicine. He is board certified in Pediatrics and is a Fellow of the American Academy of Pediatrics.- D. Christopher Chung，医学博士，自2011年6月起担任公司副总裁，负责医疗事务、质量和法规。从2003年6月至2011年6月担任集团副总裁，负责研发和工程。从2000年10月至2003年2月担任医疗主任。从2000年到2010年担任在旧金山的加州太平洋医疗中心的儿科医生。从1997年6月至2000年6月在波士顿儿童医院和哈佛医学院受训成为一名儿科医生。从1986年5月至1993年7月担任Nellcor（一家医疗设备公司）的工程师。从宾夕法尼亚大学获得文学士学位，主修计算机数学；医学博士学位来自宾夕法尼亚州的哈内曼大学医学院。他是委员会认证的儿科医生，是美国儿科科学院院士。
- D. Christopher Chung has served as our Vice President Medical Affairs, Quality and Regulatory since June 2003 and has served as our Vice President Medical Affairs since February 2003. Dr. Chung also served as our Medical Director from October 2000 to February 2003. From August 2000 to present, Dr. Chung has also served as a Pediatric Hospitalist at the California Pacific Medical Center in San Francisco. From June 1997 to June 2000 Dr. Chung trained as a pediatric resident at Boston Children's Hospital and Harvard Medical School. From May 1986 to July 1993 Dr. Chung worked as an Engineer at Nellcor, a medical device company. Dr. Chung holds a Bachelor of Arts degree in Computer Mathematics from the University of Pennsylvania and a Doctor of Medicine degree from the Medical College of Pennsylvania-Hahnemann University School of Medicine. He is board certified in Pediatrics and is a Fellow of the American Academy of Pediatrics.
- Kenneth M. Traverso
Kenneth M. Traverso自2012年12月起担任公司副总裁兼总经理，负责新生儿护理战略业务部。自2002年4月至2012年12月担任市场营销和销售的副总裁。从2000年9月至2002年4月期间担任公司副总裁，负责销售。从1999年10月至2000年7月担任DinnerNow.com公司（一个餐饮业聚合的互联网）的总裁。从1998年1月至1999年9月担任Alere医疗（门诊慢性病管理公司）西部地区的销售副总裁。从1995年5月至1998年1月担任AbTox公司（低温杀菌的公司）市场营销和销售副总裁。从1990年8月至1995年5月曾在垂穗担任多个职位，包括销售副总裁。从1984年9月至1990年7月在Nellcor（一家医疗设备公司）担任不同职位，包括西部地区的区域销售经理。持有旧金山州立大学的管理与营销理学士学位。
Kenneth M. Traverso has served as our Vice President and General Manager, Newborn Care, since October 2012. Previously, he served as Vice President Marketing and Sales from April 2002 to September 2012. From September 2000 to April 2002 he served as our Vice President Sales. From October 1999 to July 2000 Mr. Traverso served as President of DinnerNow.com Inc., an internet aggregator for the restaurant industry. From January 1998 to September 1999 Mr. Traverso served as Vice President Sales, Western Region of Alere Medical, an outpatient chronic disease management company. From May 1995 to January 1998 Mr. Traverso served as Vice President Marketing and Sales of AbTox, Inc., a low temperature sterilization company. From August 1990 to May 1995 Mr. Traverso served in various capacities at Natus, including Vice President Sales. From September 1984 to July 1990 Mr. Traverso served various positions at Nellcor, a medical device company, including Regional Sales Manager, Western Region. Mr. Traverso holds a Bachelor of Science degree in Administration & Marketing from San Francisco State University.- Kenneth M. Traverso自2012年12月起担任公司副总裁兼总经理，负责新生儿护理战略业务部。自2002年4月至2012年12月担任市场营销和销售的副总裁。从2000年9月至2002年4月期间担任公司副总裁，负责销售。从1999年10月至2000年7月担任DinnerNow.com公司（一个餐饮业聚合的互联网）的总裁。从1998年1月至1999年9月担任Alere医疗（门诊慢性病管理公司）西部地区的销售副总裁。从1995年5月至1998年1月担任AbTox公司（低温杀菌的公司）市场营销和销售副总裁。从1990年8月至1995年5月曾在垂穗担任多个职位，包括销售副总裁。从1984年9月至1990年7月在Nellcor（一家医疗设备公司）担任不同职位，包括西部地区的区域销售经理。持有旧金山州立大学的管理与营销理学士学位。
- Kenneth M. Traverso has served as our Vice President and General Manager, Newborn Care, since October 2012. Previously, he served as Vice President Marketing and Sales from April 2002 to September 2012. From September 2000 to April 2002 he served as our Vice President Sales. From October 1999 to July 2000 Mr. Traverso served as President of DinnerNow.com Inc., an internet aggregator for the restaurant industry. From January 1998 to September 1999 Mr. Traverso served as Vice President Sales, Western Region of Alere Medical, an outpatient chronic disease management company. From May 1995 to January 1998 Mr. Traverso served as Vice President Marketing and Sales of AbTox, Inc., a low temperature sterilization company. From August 1990 to May 1995 Mr. Traverso served in various capacities at Natus, including Vice President Sales. From September 1984 to July 1990 Mr. Traverso served various positions at Nellcor, a medical device company, including Regional Sales Manager, Western Region. Mr. Traverso holds a Bachelor of Science degree in Administration & Marketing from San Francisco State University.
- Jonathan Kennedy
Jonathan Kennedy于2013年4月加入垂穗，担任高级副总裁兼首席财务官。以前在Intersil公司工作，2009年4月至2013年3月担任高级副总裁兼财务总监，2008年12月至2009年4月担任临时财务总监，2005年4月至2008年12月担任公司财务总监，2004年6月至2005年4月担任财务总监。在此之前，从2000年7月至2004年6月，担任爱尔康公司的信息技术财务总监，和哈里斯公司自主技术的各种财务及资讯科技职位。他从佛罗里达中央大学获得工商管理理学学士学位，会计硕士学位。他是一名注册会计师。
Jonathan Kennedy,Mr. Kennedy was appointed to our Board of Directors in June 2016. Mr. Kennedy currently serves as Executive Vice President, General Manager and Chief Financial Officer of Natus Medical Incorporated. Before joining Natus, Mr. Kennedy was Senior Vice President and Chief Financial Officer of Intersil Corporation, a global semiconductor manufacturer, since 2009. Prior to that, he was Intersil’s Corporate Controller since 2005 and Director of Finance since 2004. Before joining Intersil, Mr. Kennedy held management roles in finance and information technology with Alcon Inc. and Harris Corporation. He holds a Bachelor of Science degree in Business Administration and a Master of Science degree in Accounting from the University of Central Florida. Mr. Kennedy is also a Certified Public Accountant.- Jonathan Kennedy于2013年4月加入垂穗，担任高级副总裁兼首席财务官。以前在Intersil公司工作，2009年4月至2013年3月担任高级副总裁兼财务总监，2008年12月至2009年4月担任临时财务总监，2005年4月至2008年12月担任公司财务总监，2004年6月至2005年4月担任财务总监。在此之前，从2000年7月至2004年6月，担任爱尔康公司的信息技术财务总监，和哈里斯公司自主技术的各种财务及资讯科技职位。他从佛罗里达中央大学获得工商管理理学学士学位，会计硕士学位。他是一名注册会计师。
- Jonathan Kennedy,Mr. Kennedy was appointed to our Board of Directors in June 2016. Mr. Kennedy currently serves as Executive Vice President, General Manager and Chief Financial Officer of Natus Medical Incorporated. Before joining Natus, Mr. Kennedy was Senior Vice President and Chief Financial Officer of Intersil Corporation, a global semiconductor manufacturer, since 2009. Prior to that, he was Intersil’s Corporate Controller since 2005 and Director of Finance since 2004. Before joining Intersil, Mr. Kennedy held management roles in finance and information technology with Alcon Inc. and Harris Corporation. He holds a Bachelor of Science degree in Business Administration and a Master of Science degree in Accounting from the University of Central Florida. Mr. Kennedy is also a Certified Public Accountant.
- Austin F. Noll, III
Austin F. Noll, III于2012年8月加盟垂穗，担任副总裁兼总经理，负责神经内科战略业务部。在医疗器械行业拥有逾24年经验。曾担任Simpirica脊柱（总部位于加州的初创公司，是一个商业化装置用于脊柱稳定的设备）的总裁兼首席执行官。在加入Simpirica脊柱前，担任NeoGuide系统（在2009年被Intuitive Surgical医疗机器人公司收购）的总裁。在加入NeoGuide系统前，他在美敦力公司担任多个职位，长达13年，担任动力手术解决方案和神经外科业务的副总裁和总经理。在美敦力公司之前，他在华润巴德和百特医疗用品担任销售职位。他从密歇根大学获得工商管理学学士学位，在迈阿密大学获得工商管理硕士学位。
Austin F. Noll, III joined Natus in August 2012 as the Vice President and General Manager, Neurology. Mr. Noll has over 24 years’ experience in the medical device industry. Mr. Noll most recently served as the President and CEO of Simpirica Spine, a California-based start-up company that developed and is commercializing a novel device for spinal stabilization, since 2009. Prior to joining Simpirica Spine, Mr. Noll was the President and CEO of NeoGuide Systems, a medical robotics company acquired by Intuitive Surgical in 2009. Prior to joining NeoGuide Systems, Mr. Noll held numerous positions at Medtronic over a 13-year period, where he served as the Vice President and General Manager of the Powered Surgical Solutions and the Neurosurgery businesses. Before Medtronic, he held sales positions at C.R. Bard and Baxter Healthcare. He received a bachelor’s degree in business administration from Miami University and a master’s of business administration from the University of Michigan.- Austin F. Noll, III于2012年8月加盟垂穗，担任副总裁兼总经理，负责神经内科战略业务部。在医疗器械行业拥有逾24年经验。曾担任Simpirica脊柱（总部位于加州的初创公司，是一个商业化装置用于脊柱稳定的设备）的总裁兼首席执行官。在加入Simpirica脊柱前，担任NeoGuide系统（在2009年被Intuitive Surgical医疗机器人公司收购）的总裁。在加入NeoGuide系统前，他在美敦力公司担任多个职位，长达13年，担任动力手术解决方案和神经外科业务的副总裁和总经理。在美敦力公司之前，他在华润巴德和百特医疗用品担任销售职位。他从密歇根大学获得工商管理学学士学位，在迈阿密大学获得工商管理硕士学位。
- Austin F. Noll, III joined Natus in August 2012 as the Vice President and General Manager, Neurology. Mr. Noll has over 24 years’ experience in the medical device industry. Mr. Noll most recently served as the President and CEO of Simpirica Spine, a California-based start-up company that developed and is commercializing a novel device for spinal stabilization, since 2009. Prior to joining Simpirica Spine, Mr. Noll was the President and CEO of NeoGuide Systems, a medical robotics company acquired by Intuitive Surgical in 2009. Prior to joining NeoGuide Systems, Mr. Noll held numerous positions at Medtronic over a 13-year period, where he served as the Vice President and General Manager of the Powered Surgical Solutions and the Neurosurgery businesses. Before Medtronic, he held sales positions at C.R. Bard and Baxter Healthcare. He received a bachelor’s degree in business administration from Miami University and a master’s of business administration from the University of Michigan.